Dante Labs announces ventures into biosimulation and drug discovery, demonstrating the predictive value of the Dante Platform
NEW YORK, April 11, 2022 (GLOBE NEWSWIRE) — Dante Labs, a global leader in genomic information and precision medicine, announces new genomic driven biosimulation and significant progress made to its drug discovery program, demonstrating the value of the Dante Platform. “Often the first concern from patients after they receive a diagnosis through whole genome sequencing […]